Form 3CCCCCIK 0001662579
C4 Therapeutics, Inc.
Initial insider ownership (Form 3) filed .
Initial statement of beneficial ownership filed by a company's officers, directors, and 10%+ owners when they first become an insider.
Filing facts
- Accession number
- 0001662579-24-000107
- Filer
- C4 Therapeutics, Inc.
- Ticker
- CCCC
- CIK
- 0001662579
- Form type
- Form 3
- Form description
- Initial insider ownership
- Filed at
- November 21, 2024
- Period of report
- November 19, 2024
- Industry
- SIC 2836Biological Products
- Filing size
- 7.2 KB
- Last verified
- August 26, 2026SecFilingDex pulls from EDGAR with daily cadence
More filings from C4 Therapeutics, Inc.
See all 42 filings from C4 Therapeutics, Inc. →Provenance
Authoritative source — SEC EDGAR
https://www.sec.gov/Archives/edgar/data/1662579/000166257924000107/0001662579-24-000107-index.htm ↗Filer's full EDGAR submission history
EDGAR · C4 Therapeutics, Inc. (0001662579) ↗SecFilingDex republishes SEC EDGAR data with provenance. EDGAR is the authoritative source. SecFilingDex is independent and not affiliated with the U.S. Securities and Exchange Commission. Nothing on this page constitutes investment, legal, tax, or other professional advice.